|
 |
HerceptinThis page contains recent news articles, when available, and an overview of Herceptin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.I'm starting the job search all over with a positive mind and look forward to finishing my Herceptin. December was full of good and bad. ... Navarre Press (blog) Money denied to patients but spent on foreign criminals - 06 Jan 2010 Shame on all those responsible for not allowing Viv Foster, pictured right, to carry on taking Herceptin on the NHS. I know The Sentinel has to report on ... Stoke & Staffordshire Herceptin pioneer's new life - Jan 5, 2010 THE woman who fought for Herceptin for Welsh breast cancer patients has spoken of her debt of gratitude to the drug a decade on from its UK launch. ... WalesOnline Study: Give Herceptin at Same Time as Chemo - Dec 15, 2009 Herceptin binds to and blocks HER2 receptors that appear on the surface of some breast cancer cells. Compared with chemo alone, giving Herceptin after chemo ... WebMD Roche: 2 Drugs With Potential To Succeed Herceptin - Dec 10, 2009 ZURICH (Dow Jones)--Roche Holding AG (ROG) is developing two drugs which have the potential to eventually succeed blockbuster drug Herceptin as breast ... Wall Street Journal EU panel backs Roche's Herceptin for stomach cancer - Dec 18, 2009 VX) blockbuster drug Herceptin for use against HER-2 positive stomach cancer, it said on Friday. Herceptin, or trastuzumab, is already approved for use in ... Reuters New treatments help fight breast cancer - Dec 30, 2009 For some women, survival is dependent on how receptive their tumors are to targeted therapies such as anti-estrogen treatments and Herceptin, ... Chicago Tribune Breaking the generic biotech barrier - Jan 4, 2010 Listed on the Kosdaq stock market, Celltrion is this month nearing clinical trials on its biosimilar of Herceptin, a breast cancer drug. ... JoongAng Daily A decade of medical breakthroughs - Jan 2, 2010 Herceptin was put on the PBS: A drug that was hailed as the first molecular-targeted breast cancer therapy in 1998, Herceptin was quickly recognised as a ... Herald Sun Herceptin Combinations Improve Survival, Lessen Heart Toxicity - Dec 23, 2009 One experimental combination is Herceptin and Tykerb (lapatinib)—two drugs that target the HER2 protein overproduced in about 25 percent of breast tumors. ... Curetoday.com (press release) GlaxoSmithKline Says Tykerb-Herceptin Combination Shows Positive Results In ... - Dec 11, 2009 ...(RTTNews) - Friday, GlaxoSmithKline plc (GSK: News ) said that the Phase III study of Tykerb or lapatinib in combination with Herceptin or trastuzumab ... RTT News Herceptin spending 'a bad investment' - Dec 21, 2009 Millions of dollars spent on 12-month Herceptin courses for breast cancer sufferers is a bad investment, women's health ... Stuff.co.nz Nanoprobes measured to deliver cancer drugs precisely - Dec 14, 2009 Nanoprobes, when coated with the breast cancer drug Herceptin, were measured to reach the endosomes of cells, mimicking the delivery of the drug on its own. ... EETimes.com Research Council chooses Vall d'Hebron hospital to study breast cancer ... - Jan 4, 2010 For the last decade to fight against this uncontrolled proliferation, the drug trastuzumab (trade name: Herceptin) has been prescribed. ... Barcelona Reporter ImmunoGen (IMGN): John McCamant's Top Stock For 2010 - Dec 31, 2009 ..."IMGN's lead drug candidate is T-DM1 which is Genentech's Herceptin with the addition of IMGN's powerful TAP technology. "The company recently delivered ... istockAnalyst.com (press release) Dennis Slamon, M.D., Ph.D., to Present Updated Results of Herceptin Trial - Dec 12, 2009 Comprehensive Cancer Center, will present updated results of his groundbreaking work with trastuzumab, currently sold as Herceptin by Genentech-Roche. ... Newswise (press release) Herceptin Worldwide Sales, 1999-2006 ----Aarkstore Enterprise - Jan 4, 2010 This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to ... PRMinds (press release) It's Good to Talk: Changing How Nerves Communicate in Congestive Heart Failure - Jan 4, 2010 ...read more Herceptin Does Not Increase Heart Failure In Patients Long-Term (June 4, 2007) — Risk of congestive heart failure in women treated with ... Science Daily (press release) Committee For Medicinal Products For Human Use Post-Authorisation Summary Of ... - Dec 18, 2009 The Marketing Authorisation Holder for this medicinal product is Roche Registration Ltd. Herceptin in combination with capecitabine or 5-fluorouracil and ... PharmaLive.com (press release) Herceptin to be preferred target therapy medication - Dec 22, 2009 Starting in January, BNHI will pay for target therapy drug Herceptin for eligible early stage breast cancer cases. Currently, there are about 450 patients ... China Post Women's Health Policy Report Highlights Studies From Recent Breast Cancer ... - Dec 16, 2009 At the symposium, researchers presented data from the five years of the 10-year study showing that women in both Herceptin groups were more likely to remain ... Medical News Today (press release) Roche-ImmunoGen to Start T-DM1 Trials - Dec 13, 2009 Herceptin global sales totaled $3.8 billion in the first nine months of 2009 and $4.7 billion in sales in 2008, according to Roche. ... TheStreet.com Cancer Vaccine Shows Benefit in Early Human Clinical Trial - Jan 4, 2010 That is, it works similar to the synthetic antibody-based drug Herceptin, but because the vaccines stimulate the body's own antibodies against the tumor, ... HealthNewsDigest.com Information on estimated cost of Herceptin released - Dec 14, 2009 Minister of Health Tony Ryall has released some information on the estimated cost of the 12-month programme of the breast cancer drug Herceptin, ... Otago Daily Times Beach 'girl' becomes honorary officer - Dec 30, 2009 Dr Chris Walsh fought government drug agency Pharmac when it refused to fund a 12-month course of Herceptin for women with aggressive breast cancer. ... Manawatu Standard Market Report -- In Play (ARIA) - Dec 14, 2009 ...its Phase 2 study evaluating oral ridaforolimus in combination with trastuzumab (Herceptin(R)) in patients with resistant, metastatic breast cancer. ... MSN Money YM Biosciences Claims Collaboration with Canada's NRC-BRI Yielded Novel ... - Dec 10, 2009 The new candidates have been designed to bind to HER2/neu on cancer cells but, in contrast to Herceptin, only minimally bind to HER2 on healthy cardiac ... Genetic Engineering News (press release) Prevention better than promise of a cure - Dec 30, 2009 Other advances have been made for cancer patients using monoclonal antibodies such as trastuzumab (Herceptin) and bevacizumab (Avastin). ... Financial Times Treatment Updates - Dec 23, 2009 ...—Laura Beil Taking Herceptin (trastuzumab) with, as opposed to after, chemotherapy helped more women live longer without a recurrence, new research found. ... Curetoday.com (press release) Herceptin receives positive opinion in record time for the treatment of HER2 ... - Dec 19, 2009 Herceptin has received positive opinion in Europe for this new indication in record time because of the high unmet medical need and the strength of the data ... PipelineReview.com (press release) The medical milestones that defined the noughties - Jan 4, 2010 And a pivotal moment in the treatment of thousands of patients was the introduction of Herceptin - a drug which targets the HER2 protein that fuels around a ... BBC News A Battle Close To Home: Thirty Eight Years After Nixon's Declaration Of War - Dec 14, 2009 At the turn of this century, newspapers and magazines heralded the advent of targeted therapies Herceptin and Gleevec as evidence that cancer would be ... Huffington Post (blog) New Zealanders' life expectancy keeps increasing - Dec 28, 2009 Some average New Zealanders' extra years on Earth will be attributable to developments in medical science - the next-generation Herceptin, perhaps, ... New Zealand Herald 39 Quebecers with breast cancer wrongly treated - Dec 16, 2009 In the other two cases, the tests recommended treatment with breast cancer drug Herceptin. The health minister said all women affected by the erroneous ... CBC.ca MUM NEEDS £16000 TO STAY ALIVE - Dec 26, 2009 The mother-of-two, pictured right, has already spent £10000 on three-weekly doses of Herceptin since first being told by NHS Stoke-on-Trent that she could ... Stoke & Staffordshire SABCS: No Need for Anthracycline with Trastuzumab - Dec 12, 2009 SAN ANTONIO -- Eliminating the anthracycline from chemotherapy when using trastuzumab (Herceptin) may be just as effective long term, with less risk of ... MedPage Today Adimab Proves Fast Antibody Discovery Tool to Merck, Roche; Snags New Deal ... - Dec 17, 2009 ...drugs like rituximab (Rituxan) and trastuzumab (Herceptin), which can zero in on specific targets on diseased cells, while sparing healthy ones. ... Xconomy More meds in the state-subsidized basket - Dec 23, 2009 The drugs Herceptin and Tykerb, for the treatment of metastatic breast cancer in 200 patients per year is on the list of recommendations, along with the ... Ha'aretz Press digest - Dec 23, 2009 In another story, The Times says that a year after the state started providing Herceptin to cancer patients, a patient is considering selling her home to ... Times of Malta New Cancer Target: PARP - Dec 16, 2009 This treatment will likely be helpful in a minority of TNBC, yet when Herceptin came out, it was almost a failed drug until breast cancer patients were ... Gerson Lehrman Group The Top Five Biotech Innovations of the 2000s - Dec 14, 2009 1) Cancer therapies such as Roche/Genentech's trastuzumab (Herceptin) and Celgene's lenalidomide (Revlimid). 2) HIV therapies such as Gilead Sciences' ... Xconomy Therapeutic Monoclonal Antibodies Markets----Aarkstore Enterprise - Dec 29, 2009 Areas such as breast cancer therapy have benefited greatly since the advent of drugs like Herceptin (trastuzumab) that interferes with the HER2/neu receptor ... PRMinds (press release) Guide to a good life: When all hope is lost, pray - Jan 1, 2010 Lella is on the drug Herceptin to keep the cancer in remission. She goes for physiotherapy weekly to try to reduce the fluid trapped in her right arm where ... National Post Obamacare: The Potential For Stifling Medical Advancement and Innovation - Dec 12, 2009 It was the first big test of combining Herceptin and Tykerb. In a study of 300 patients, women receiving both drugs lived nearly five months longer than ... First Things (blog) With a little help from my friends - Dec 23, 2009 The scientists have developed a computer model that will help predict a patient's response to the drug Herceptin and as such has a huge potential impact on ... Campbeltown Courier Martell Biosystems Seeks Investors to Develop Non-Invasive Breast Cancer Dx - Dec 28, 2009 Because the presence of HER-2 is indicative of tumors that may respond to treatment with Herceptin, early and accurate detection of the biomarker could help ... GenomeWeb Daily News Daiichi Sankyo Looks For Acquisitions In Continued US Push - Dec 18, 2009 ...sold by Pfizer Inc. (PFE) with 2008 sales of $847 million, and Roche Holding AG's (RHHBY) breast-cancer drug, Herceptin, with 2008 sales of $1.4 billion. Wall Street Journal Trastuzumab plus chemotherapy for maximum benefit - Dec 18, 2009 In the United States, Herceptin is approved for use either following or concurrently with chemotherapy," said Perez. "However, currently in some countries ... ecancermedicalscience EU Panel Backs DuoCover From Bristol-Myers Squibb Pharma - Dec 18, 2009 Herceptin (trastuzumab), from Roche Registration Ltd, to extend the indication to include the treatment of patients with HER2 positive metastatic ... Wall Street Journal Anthony Pawson - Jan 1, 2010 By unravelling the language of cells, and specific proteins within cells, Dr. Pawson has paved the way for others to develop drugs like Gleevec, Herceptin ... Globe and Mail GSK finds drug that may outdo Herceptin - Jun 5, 2006 By Katherine Griffiths, City Correspondent. Pharmaceutical giant GlaxoSmithKline will publish data today showing its experimental breast cancer pill might ... Telegraph.co.uk Call for more, earlier use of Herceptin Trial finds drug effective... - Oct 20, 2005 The cancer drug Herceptin, which has shown promise in battling the recurrence of breast cancer, gained renewed attention Wednesday, when an editorial in the ... San Francisco Chronicle Herceptin reduces cancer deaths by a third, study shows - Jan 5, 2007 Herceptin reduces the risk of death significantly if given to appropriate breast cancer patients after surgery and chemotherapy, a trial has indicated. ... Times Online Cancer victim loses court fight over Herceptin - Feb 15, 2006 Breast cancer victim Ann Marie Rogers today lost her legal challenge over her local NHS trust's refusal to fund treatment with the drug Herceptin. ... Independent Glaxo cancer pill seen limited threat to Herceptin - Mar 14, 2007 By Ben Hirschler. LONDON, March 14 (Reuters) - GlaxoSmithKline Plc's (GSK.L) once-a-day breast cancer pill Tykerb, approved in the United States on Tuesday, ... Reuters Genentech Jumps on Herceptin News - Apr 26, 2005 By Althea Chang 04/26/05 - 10:44 AM EDT. Genentech (DNA Quote) shares jumped Tuesday after the company announced positive interim results for its drug ... TheStreet.com - TheStreet.com (subscription) NHS drug watchdog backs Herceptin - Jun 9, 2006 The NHS's drugs watchdog says people with early stage breast cancer should be able to get the drug Herceptin. The draft guidance from the National Institute ... BBC News Breakout drug Herceptin brings new age in breast cancer care - Oct 12, 2008 By Larry Armstrong for USA TODAY. By Liz Szabo, USA TODAY. When she was diagnosed in 1989, Bradfield's tumor — which produced an overabundance of a protein ... USA Today Herceptin enhances Tykerb for breast cancer -study - May 15, 2008 LOS ANGELES, May 15 (Reuters) - A combination of targeted cancer drugs -- GlaxoSmithKline Plc's (GSK.L) Tykerb and Genentech Inc's DNA.N Herceptin -- works ... Reuters Herceptin Still Improves Odds Against Breast Cancer - Jun 4, 2007 By Amanda Gardner. MONDAY, June 4 (HealthDay News) -- After almost a decade of use, Herceptin continues to prolong the lives of women with a particularly ... Washington Post Hewitt steps in as trust refuses Herceptin to cancer patient - Nov 9, 2005 The health secretary, Patricia Hewitt, last night intervened in a row over funding for the breast cancer drug Herceptin as NHS managers defied her attempts ... guardian.co.uk Herceptin increases risk of heart disease - Aug 15, 2006 BEIJING, Aug. 15 (Xinhuanet) -- Herceptin, the drug prolonging the survival of women with breast cancer, increases the risk of cardiac toxicity than ... æ–°å?Žç½‘ Early Herceptin combination cures half breast cancer cases - Apr 19, 2008 Breast cancer can be completely eradicated in almost half of women patients who are treated early with a combination of Herceptin and a traditional ... Times Online UK's Hewitt says Roche drug Herceptin to be given on National Health ... - Oct 5, 2005 LONDON (AFX) - UK secretary of state for health Patricia Hewitt has announced that women who are diagnosed with early stage breast cancer from this week ... Forbes British woman wins Herceptin drug case - Apr 13, 2006 LONDON - A British woman with early-stage breast cancer won a legal appeal yesterday to force her local health authority to pay for the potentially ... New Zealand Herald New study to compare Genentech's Herceptin vs. Glaxo's Tykerb - Feb 29, 2008 By Elena Berton. LONDON (MarketWatch) -- Two drugs that treat an aggressive form of breast cancer, GlaxoSmithKline PLC's Tykerb and Genentech Inc's ... MarketWatch Herceptin eradicates aggressive tumors: study - Sep 26, 2007 ZURICH (Reuters) - Adding Herceptin to chemotherapy before surgery eradicates tumors in nearly three times as many women with inflammatory breast cancer as ... Reuters UK FDA Expands Herceptin Use for Breast Cancer - Nov 17, 2006 By Miranda Hitti. The FDA will allow Herceptin, a biological cancer drug, to be used to treat an aggressive type of breast cancer after surgery. ... FOXNews HERCEPTIN 'CUTS RISK' OF CANCER - Dec 9, 2005 THE controversial drug Herceptin cuts the risk of early stage aggressive breast cancer returning after treatment by up to 51 per cent, a study published ... Mirror.co.uk Herceptin 'may be less effective than thought' - May 16, 2008 The breast cancer drug Herceptin may be up to a third less effective than widely thought, according to experts who have analysed unpublished data from a ... Telegraph.co.uk Woman wins Herceptin court fight - Apr 12, 2006 A breast cancer patient should have the drug Herceptin, according to a landmark ruling from the Court of Appeal. Ann Marie Rogers of Swindon, Wilts, ... BBC News … orders health trust to fund interim course of Herceptin for cancer... - Dec 22, 2005 A high court judge yesterday ordered NHS managers to pay for a woman with breast cancer to have the unlicensed drug Herceptin until her legal challenge to ... guardian.co.uk Roche's Herceptin gets Europe OK for breast cancer - May 3, 2007 ZURICH, May 3 (Reuters) - Swiss drugmaker Roche Holding AG (ROG.VX) said on Thursday its Herceptin had been approved in Europe for the treatment of advanced ... Reuters Roche says Herceptin with chemo prolongs survival - May 30, 2008 ZURICH (Reuters) - Roche Holding AG's Herceptin, when added to chemotherapy Xeloda, prolonged survival without progression of breast cancer by three months ... Reuters UK Herceptin adds year to cancer survival rate - Dec 16, 2006 By Celia Hall, Medical Editor. The drug Herceptin has been found to increase survival in women with advanced breast cancer by nearly a year, ... Telegraph.co.uk What Is Herceptin and What Are Its Side Effects? - Oct 1, 2007 Question: What is Herceptin and what are its side effects? What are its potential side effects versus benefits? Dr. Nancy Davidson answers the question: ... ABC News Mother in Herceptin legal battle - Nov 7, 2005 A mother-of-four who was refused the cancer drug Herceptin on the NHS is to take her fight to the High Court. Papers were lodged at the court last week ... BBC News Roche sees Herceptin growth rate levelling off - Jan 30, 2008 BASEL, Switzerland, Jan 30 (Reuters) - Roche Holding AG (ROG.VX) sees a levelling off in growth rates of its cancer drug Herceptin after its fast take-up ... Reuters 'Wonder drug' Herceptin given licence - May 24, 2006 The breast cancer drug Herceptin could be approved for widespread use on the NHS in the next few weeks after it received its UK licence today. ... Daily Mail Drug found effective against early breast cancer - Oct 31, 2005 The drug, Herceptin, targets only diseased cells and is already used for ... The Herceptin studies were published Thursday in The New England Journal of ... msnbc.com Herceptin sales boost drugmaker - Apr 18, 2007 Strong demand for Herceptin and other cancer treatments have boosted sales at Swiss drugmaker Roche. Roche said sales rose 16% to 11.4bn Swiss francs ... BBC News GlaxoSmithKline tests Tykerb against Herceptin in early breast cancer... - May 12, 2008 LONDON (Thomson Financial) - GlaxoSmithKline (nyse: GSK - news - people ) Plc has announced that it has launched large-scale trials comparing its late-stage ... Forbes Breast cancer patient brings Herceptin test case - Feb 6, 2006 By Times Online and PA News. A mother of three today told the High Court that her local NHS trust's refusal to give her the breast cancer drug Herceptin was ... Times Online Roche step is positive signal on Herceptin - Dec 9, 2005 By James Kanter. PARIS — The Swiss drug maker Roche is donating £1.5 million to the British government to help screen women for breast cancer, ... New York Times … drug Pertuzumab shows promising results combined with Herceptin - Jun 4, 2007 Pertuzumab have shown substantial anti-tumour activity in patients with pre-treated HER2 positive metastatic breast cancer when combined with Herceptin. ... Forbes Glaxo's Tykerb Goes Head-To-Head with Herceptin - Mar 3, 2008 LONDON (Reuters) - GlaxoSmithKline Plc's (GSK.L: Quote, Profile, Research) new breast cancer drug Tykerb is to go head-to-head with Genentech Inc's DNA. ... Reuters UK Doctors say Herceptin is a waste of money - Nov 24, 2006 The cost of making the breast cancer drug Herceptin available on the NHS will mean that health trusts have to deny patients other treatments, according to ... Times Online New drug highlights world's largest cancer meeting. - May 18, 2005 Oncologists hailed the drug, Herceptin, as one of the greatest advances in ... Herceptin is used to treat women with an aggressive type of breast cancer ... Free with registration - Chicago Tribune - AccessMyLibrary.com … European Medicines Agency recommends Herceptin for further approvals - Mar 26, 2007 ZURICH (AFX) - Roche Holdings AG said the European Union's Committee for Human Medicinal Products has issued a positive recommendation for the use of ... Forbes 'Dose-Dense' Chemo Cuts Herceptin Heart Risk-Study - Mar 7, 2008 LOS ANGELES (Reuters) - Combining targeted breast cancer treatment Herceptin with a more frequent chemotherapy regimen reduces the risk of heart problems ... Reuters UK Herceptin receives final go-ahead - Aug 22, 2006 The breast cancer drug Herceptin must be funded by the NHS, the drugs watchdog has said. The National Institute for health and Clinical Excellence made its ... BBC News Genentech Shares May See Upside On Herceptin Strength - Aug 19, 2005 Banc of America Securities initiated coverage of Genentech (nyse: DNA - news - people ) with a "buy" rating and target price of $105. ... Forbes Herceptin approved for nine weeks - Mar 20, 2007 District health boards have provisionally approved funding for a nine-week treatment course of the breast cancer drug Herceptin following a recommendation ... TVNZ Herceptin gets European approval in record time. - Apr 28, 2006 The breast cancer drug Herceptin has been approved in record time on the way to gaining a licence for use in early cases of the disease. ... Pay-Per-View - Independent - Factiva, from Dow Jones Japan clears Herceptin for breast cancer: Roche - Feb 29, 2008 ZURICH (Reuters) - Japan's health authorities have approved Roche's cancer drug Herceptin for the treatment of HER2-positive breast cancer, ... Reuters BREAST CANCER Herceptin afte ... - Oct 25, 2005 THIS STUDY randomly assigned 3387 women with HER2-positive breast cancer who had completed surgery and chemotherapy to receive trastuzumab (Herceptin) ... Pay-Per-View - Washington Post - ProQuest Archiver Herceptin risks 'being ignored' - Aug 23, 2007 IT WAS hailed as the breast cancer wonder drug. But nearly six years after Herceptin was first subsidised for late-stage sufferers, an analysis of all ... The Age NHS Herceptin for breast cancer man - May 9, 2006 By Celia Hall, Medical Editor. A man with early but aggressive breast cancer was told yesterday that he could receive an expensive drug on the NHS. ... Telegraph.co.uk Herceptin 'now an election issue' - Aug 8, 2008 Breast cancer patients are pinning their hopes on a change of Government after Pharmac again rejected a bid to extend funding for the costly drug Herceptin. ... Stuff.co.nz Herceptin decision 'breakthrough' - Oct 18, 2005 More than 100 breast cancer patients in Cornwall and Devon could soon be prescribed the drug Herceptin. The decision by South West Peninsula Health ... BBC News |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |